Westham Competitors and Similar CompaniesClear all

Westham's competitors and similar companies include Alnylam Pharmaceuticals, Merus and Olainfarm.
Westham
Westham
Westham is a biotech company that provides mosquito control solutions.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Merus
Merus
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
Olainfarm
Olainfarm
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
Founding Date
Founding Date
2006
Founding Date
2002
Founding Date
2003
Founding Date
1972
Type
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dallas, US HQ
Hod Hasharon, IL
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Utrecht, NL HQ
Cambridge, US
Locations
Olaine, LV HQ
Employees
Employees
918% decrease
Employees
1,32324% increase
Employees
1725% increase
Employees
2,191
Valuation ($)
Valuation ($)
N/A
Valuation ($)
18.8 b
Valuation ($)
2.5 b
Valuation ($)
150.2 m
Twitter followers
Twitter followers
N/A
Twitter followers
16.3 k
Twitter followers
N/A
Twitter followers
716
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
23
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
86.96%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$1.8b (FY, 2023)
Revenue (est.)
$41.6m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$268.2m (FY, 2023)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$1.6b (FY, 2023)
Gross profit
$41.6m (FY, 2022)
Gross profit
N/A
Net income
Net income
N/A
Net income
($440.2m) (FY, 2023)
Net income
($131.2m) (FY, 2022)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 1.5b
Total funding raised
$ 149.3m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Alnylam Pharmaceuticals
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

View company
Merus
HQ
Utrecht, NL
Employees
172↑ 5% increase

Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.

View company
Olainfarm
HQ
Olaine, LV
Employees
2,191

Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.

View company